These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Wagner GC; Carelli RM; Jarvis MF Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):221-8. PubMed ID: 3992009 [TBL] [Abstract][Full Text] [Related]
25. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. Volz TJ; Hanson GR; Fleckenstein AE J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775 [TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800 [TBL] [Abstract][Full Text] [Related]
27. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Johnson-Davis KL; Fleckenstein AE; Wilkins DG Eur J Pharmacol; 2003 Dec; 482(1-3):151-4. PubMed ID: 14660016 [TBL] [Abstract][Full Text] [Related]
28. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity. Miller DK; Dopheide MM; Smith SM; Casteel SW Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525 [TBL] [Abstract][Full Text] [Related]
29. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Cass WA; Smith MP; Peters LE Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922 [TBL] [Abstract][Full Text] [Related]
30. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. Ji J; McDermott JL; Dluzen DE J Neuroendocrinol; 2007 Sep; 19(9):725-31. PubMed ID: 17680888 [TBL] [Abstract][Full Text] [Related]
35. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. Brown JM; Gouty S; Iyer V; Rosenberger J; Cox BM J Neurochem; 2006 Jul; 98(2):495-505. PubMed ID: 16749908 [TBL] [Abstract][Full Text] [Related]
36. Tolerance to the neurotoxic effects of methamphetamine in young rats. Riddle EL; Kokoshka JM; Wilkins DG; Hanson GR; Fleckenstein AE Eur J Pharmacol; 2002 Jan; 435(2-3):181-5. PubMed ID: 11821024 [TBL] [Abstract][Full Text] [Related]
37. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine. Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959 [TBL] [Abstract][Full Text] [Related]
38. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341 [TBL] [Abstract][Full Text] [Related]
39. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Bourque M; Liu B; Dluzen DE; Di Paolo T Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264 [TBL] [Abstract][Full Text] [Related]
40. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats. He J; Yang Y; Yu Y; Li X; Li XM Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]